• Article

Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction

Citation

Gardner, E. L., Bi, G-H., Thakur, G., Makriyannis, A., Seltzman, H. H., He, X-H., & Xi, Z-X. (2016). Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction. International Journal of Neuropsychopharmacology, 19, 152-152.